ArticleClinical, cosmetic and investigational dermatology2022

CD133, but Not CD44, May Serve as a Novel Biomarker for Differential Diagnosis Between Basal Cell Carcinoma and Trichoblastomas.

Yalan Bi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.